Table 1. Pretreatment serum KIT, SCF,... | American Society of Hematology

Table 1.

Pretreatment serum KIT, SCF, and VEGF concentrations of GIST patients and controls

	Patients with GISTs, median (range)^*	Controls, median (range)†	P‡
KIT, AU/mL	292 (130-875)	238 (90-514)	.037
SCF, pg/mL	645 (290-1600)	950 (565-1600)	< .0001
VEGF, pg/mL	303 (24-2400)	190 (10-775)	.013

	Patients with GISTs, median (range)^*	Controls, median (range)†	P‡
KIT, AU/mL	292 (130-875)	238 (90-514)	.037
SCF, pg/mL	645 (290-1600)	950 (565-1600)	< .0001
VEGF, pg/mL	303 (24-2400)	190 (10-775)	.013

N = 66.

N = 40.

P value determined by Mann-Whitney test.